INDUSTRY OVERVIEW
The Forensic Genomics is Growing at 11.00% and is expected to reach 1.8Billion by 2033. Below mentioned are some of the dynamics shaping the Forensic Genomics.Forensic Genomics Market Size in (USD Billion) CAGR Growth Rate 11.00%
| Study Period | 2020-2033 |
| Market Size (2025): | 0.7Billion |
| Market Size (2033): | 1.8Billion |
| CAGR (2025 - 2033): | 11.00% |
| Fastest Growing Region | Asia-Pacific |
| Dominating Region | North America |
www.htfmarketinsights.com
Forensic Genomics employs advanced genomic sequencing and analysis techniques to identify individuals, species, and genetic relationships in forensic investigations and research. It includes next-generation sequencing, microarrays, PCR, and SNP genotyping. Used extensively in law enforcement, paternity testing, disease outbreaks, and wildlife monitoring, this field enables high accuracy, speed, and detailed genetic insights. Innovations focus on rapid sequencing, data analytics, and portable devices to support forensic casework and research globally.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Regulatory Landscape
- Regulated under strict privacy, ethical, and data security laws (GDPR, HIPAA). Labs must comply with accreditation standards (ISO 17025) and chain-of-custody protocols. Emerging regulations on genomic data sharing and forensic bioinformatics. Manufacturing includes specialized reagents and kits under GMP.
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Law Enforcement Demand
- Genomic Advances
- Data Analytics
- Portable Devices
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- Data Security
- Ethical Concerns
- Cost
- Regulatory Complexity
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Next-Gen Sequencing
- AI & Machine Learning
- Portable Genomics
- Data Sharing
Market Opportunities:
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Growth In Crime Labs
- Personalized Medicine
- Wildlife Forensics
- Biodefense
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- Next-Generation Sequencing
- Microarray Analysis
- PCR-based Methods
- DNA Barcoding
Forensic Genomics Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Crime Investigation
- Paternity Testing
- Disease Research
- Wildlife Conservation
- Biodefense
Forensic Genomics Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Asia-Pacific is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Asia-Pacific
![Asia-Pacific dominates Forensic Genomics Market [2020 to 2025]](https://www.htfmarketinsights.com/assets_n/img/region/continent/asia_pacific_wn.png)
Dominating Region
North America
![North America dominates Forensic Genomics Market [2020 to 2025]](https://www.htfmarketinsights.com/assets_n/img/region/continent/north_america_wn.png)
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- Thermo Fisher Scientific (USA)
- Illumina (USA)
- Qiagen (Germany)
- BGI Genomics (China)
- Verogen (USA)
- PerkinElmer (USA)
- Bio-Rad Laboratories (USA)
- Eurofins Scientific (Luxembourg)
- Myriad Genetics (USA)
- Agilent Technologies (USA)
- Oxford Nanopore Technologies (UK)
- Guardant Health (USA)
- NGS Health (Singapore)
- Invitae Corporation (USA)
Forensic Genomics Market Segmentation by Players
www.htfmarketinsights.com
Regional Analysis
- Growing market in law enforcement and legal sectors worldwide
Market Entropy
- In May 2025, a biotech company launched a cloud-based forensic genomics service supporting rapid DNA phenotyping, kinship analysis, and population variant detection. The platform is designed for law enforcement, POC mobile labs, and academic labs needing secure chain-of-custody workflows.
Merger & Acquisition
- May 2025 – Verogen, Inc. acquired a UK-based crime lab tech company. They launched a new rapid forensic genomics suite for on-site crime scene DNA decoding.
Regulatory Landscape
- Regulated under strict privacy, ethical, and data security laws (GDPR, HIPAA). Labs must comply with accreditation standards (ISO 17025) and chain-of-custody protocols. Emerging regulations on genomic data sharing and forensic bioinformatics. Manufacturing includes specialized reagents and kits under GMP.
Patent Analysis
- Extensive patents in sequencing technologies and analysis methods
Investment and Funding Scenario
- Strong investment fueled by government and private sector
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2025 |
|
Based Year Market Size (2023) |
0.7Billion |
|
Historical Period |
2020 to 2025 |
|
CAGR (2025 to 2033) |
11.00% |
|
Forecast Period |
2025 to 2033 |
|
Forecasted Period Market Size (2033) |
1.8Billion |
|
Scope of the Report |
Segmentation by Type Next-Generation Sequencing,Microarray Analysis,PCR-based Methods,DNA Barcoding, Segmentation by Application Crime Investigation,Paternity Testing,Disease Research,Wildlife Conservation,Biodefense, Sales Channel |
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
Thermo Fisher Scientific (USA),Illumina (USA),Qiagen (Germany),BGI Genomics (China),Verogen (USA),PerkinElmer (USA),Bio-Rad Laboratories (USA),Eurofins Scientific (Luxembourg),Myriad Genetics (USA),Agilent Technologies (USA),Oxford Nanopore Technologies (UK),Guardant Health (USA),NGS Health (Singapore),Invitae Corporation (USA) |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Forensic Genomics - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Forensic Genomics Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Forensic Genomics Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Forensic Genomics Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Law Enforcement Demand
- 3.1.2 Genomic Advances
- 3.1.3 Data Analytics
- 3.1.4 Portable Devices
-
3.2 Available Opportunities
- 3.2.1 Growth In Crime Labs
- 3.2.2 Personalized Medicine
- 3.2.3 Wildlife Fo
-
3.3 Influencing Trends
- 3.3.1 Next-Gen Sequencing
- 3.3.2 AI & Machine Learning
- 3.3.3 Portable Gen
-
3.4 Challenges
- 3.4.1 Data Security
- 3.4.2 Ethical Concerns
- 3.4.3 Cost
- 3.4.4 Regulatory Complex
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Forensic Genomics Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Forensic Genomics Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Forensic Genomics : Competition Benchmarking & Performance Evaluation
- 5.1 Global Forensic Genomics Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Forensic Genomics Revenue 2025
- 5.3 Global Forensic Genomics Sales Volume by Manufacturers (2025)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 Ansoff Matrix
- 5.6 FPNV Positioning Matrix
Chapter 6: Global Forensic Genomics Market: Company Profiles
- 6.1 Thermo Fisher Scientific (USA)
- 6.1.1 Thermo Fisher Scientific (USA) Company Overview
- 6.1.2 Thermo Fisher Scientific (USA) Product/Service Portfolio & Specifications
- 6.1.3 Thermo Fisher Scientific (USA) Key Financial Metrics
- 6.1.4 Thermo Fisher Scientific (USA) SWOT Analysis
- 6.1.5 Thermo Fisher Scientific (USA) Development Activities
- 6.2 Illumina (USA)
- 6.3 Qiagen (Germany)
- 6.4 BGI Genomics (China)
- 6.5 Verogen (USA)
- 6.6 PerkinElmer (USA)
- 6.7 Bio-Rad Laboratories (USA)
- 6.8 Eurofins Scientific (Luxembourg)
- 6.9 Myriad Genetics (USA)
- 6.10 Agilent Technologies (USA)
- 6.11 Oxford Nanopore Technologies (UK)
- 6.12 Guardant Health (USA)
- 6.13 NGS Health (Singapore)
- 6.14 Invitae Corporation (USA)
- 6.15 Roche Diagnostics (Switzerland)
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Forensic Genomics by Type & Application (2020-2033)
-
7.1 Global Forensic Genomics Market Revenue Analysis (USD Million) by Type (2020-2025)
- 7.1.1 Next-Generation Sequencing
- 7.1.2 Microarray Analysis
- 7.1.3 PCR-based Methods
- 7.1.4 DNA Barcoding
- 7.1.5 SNP Genotyping
-
7.2 Global Forensic Genomics Market Revenue Analysis (USD Million) by Application (2020-2025)
- 7.2.1 Crime Investigation
- 7.2.2 Paternity Testing
- 7.2.3 Disease Research
- 7.2.4 Wildlife Conservation
- 7.2.5 Biodefense
- 7.3 Global Forensic Genomics Market Revenue Analysis (USD Million) by Type (2025-2033)
- 7.4 Global Forensic Genomics Market Revenue Analysis (USD Million) by Application (2025-2033)
Chapter 8 : North America Forensic Genomics Market Breakdown by Country, Type & Application
- 8.1 North America Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 8.2.1 Next-Generation Sequencing
- 8.2.2 Microarray Analysis
- 8.2.3 PCR-based Methods
- 8.2.4 DNA Barcoding
- 8.2.5 SNP Genotyping
-
8.3 North America Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 8.3.1 Crime Investigation
- 8.3.2 Paternity Testing
- 8.3.3 Disease Research
- 8.3.4 Wildlife Conservation
- 8.3.5 Biodefense
- 8.4 North America Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 8.5 North America Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 8.6 North America Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Forensic Genomics Market Breakdown by Country, Type & Application
- 9.1 LATAM Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 9.2.1 Next-Generation Sequencing
- 9.2.2 Microarray Analysis
- 9.2.3 PCR-based Methods
- 9.2.4 DNA Barcoding
- 9.2.5 SNP Genotyping
-
9.3 LATAM Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 9.3.1 Crime Investigation
- 9.3.2 Paternity Testing
- 9.3.3 Disease Research
- 9.3.4 Wildlife Conservation
- 9.3.5 Biodefense
- 9.4 LATAM Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 9.5 LATAM Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 9.6 LATAM Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 10 : West Europe Forensic Genomics Market Breakdown by Country, Type & Application
- 10.1 West Europe Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 10.2.1 Next-Generation Sequencing
- 10.2.2 Microarray Analysis
- 10.2.3 PCR-based Methods
- 10.2.4 DNA Barcoding
- 10.2.5 SNP Genotyping
-
10.3 West Europe Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 10.3.1 Crime Investigation
- 10.3.2 Paternity Testing
- 10.3.3 Disease Research
- 10.3.4 Wildlife Conservation
- 10.3.5 Biodefense
- 10.4 West Europe Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 10.5 West Europe Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 10.6 West Europe Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 11 : Central & Eastern Europe Forensic Genomics Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 11.2.1 Next-Generation Sequencing
- 11.2.2 Microarray Analysis
- 11.2.3 PCR-based Methods
- 11.2.4 DNA Barcoding
- 11.2.5 SNP Genotyping
-
11.3 Central & Eastern Europe Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 11.3.1 Crime Investigation
- 11.3.2 Paternity Testing
- 11.3.3 Disease Research
- 11.3.4 Wildlife Conservation
- 11.3.5 Biodefense
- 11.4 Central & Eastern Europe Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 11.5 Central & Eastern Europe Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 11.6 Central & Eastern Europe Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 12 : Northern Europe Forensic Genomics Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 12.2.1 Next-Generation Sequencing
- 12.2.2 Microarray Analysis
- 12.2.3 PCR-based Methods
- 12.2.4 DNA Barcoding
- 12.2.5 SNP Genotyping
-
12.3 Northern Europe Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 12.3.1 Crime Investigation
- 12.3.2 Paternity Testing
- 12.3.3 Disease Research
- 12.3.4 Wildlife Conservation
- 12.3.5 Biodefense
- 12.4 Northern Europe Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 12.5 Northern Europe Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 12.6 Northern Europe Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 13 : Southern Europe Forensic Genomics Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 13.2.1 Next-Generation Sequencing
- 13.2.2 Microarray Analysis
- 13.2.3 PCR-based Methods
- 13.2.4 DNA Barcoding
- 13.2.5 SNP Genotyping
-
13.3 Southern Europe Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 13.3.1 Crime Investigation
- 13.3.2 Paternity Testing
- 13.3.3 Disease Research
- 13.3.4 Wildlife Conservation
- 13.3.5 Biodefense
- 13.4 Southern Europe Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 13.5 Southern Europe Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 13.6 Southern Europe Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 14 : East Asia Forensic Genomics Market Breakdown by Country, Type & Application
- 14.1 East Asia Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 14.2.1 Next-Generation Sequencing
- 14.2.2 Microarray Analysis
- 14.2.3 PCR-based Methods
- 14.2.4 DNA Barcoding
- 14.2.5 SNP Genotyping
-
14.3 East Asia Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 14.3.1 Crime Investigation
- 14.3.2 Paternity Testing
- 14.3.3 Disease Research
- 14.3.4 Wildlife Conservation
- 14.3.5 Biodefense
- 14.4 East Asia Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 14.5 East Asia Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 14.6 East Asia Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 15 : Southeast Asia Forensic Genomics Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 15.2.1 Next-Generation Sequencing
- 15.2.2 Microarray Analysis
- 15.2.3 PCR-based Methods
- 15.2.4 DNA Barcoding
- 15.2.5 SNP Genotyping
-
15.3 Southeast Asia Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 15.3.1 Crime Investigation
- 15.3.2 Paternity Testing
- 15.3.3 Disease Research
- 15.3.4 Wildlife Conservation
- 15.3.5 Biodefense
- 15.4 Southeast Asia Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 15.5 Southeast Asia Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 15.6 Southeast Asia Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 16 : South Asia Forensic Genomics Market Breakdown by Country, Type & Application
- 16.1 South Asia Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 16.2.1 Next-Generation Sequencing
- 16.2.2 Microarray Analysis
- 16.2.3 PCR-based Methods
- 16.2.4 DNA Barcoding
- 16.2.5 SNP Genotyping
-
16.3 South Asia Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 16.3.1 Crime Investigation
- 16.3.2 Paternity Testing
- 16.3.3 Disease Research
- 16.3.4 Wildlife Conservation
- 16.3.5 Biodefense
- 16.4 South Asia Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 16.5 South Asia Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 16.6 South Asia Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 17 : Central Asia Forensic Genomics Market Breakdown by Country, Type & Application
- 17.1 Central Asia Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 17.2.1 Next-Generation Sequencing
- 17.2.2 Microarray Analysis
- 17.2.3 PCR-based Methods
- 17.2.4 DNA Barcoding
- 17.2.5 SNP Genotyping
-
17.3 Central Asia Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 17.3.1 Crime Investigation
- 17.3.2 Paternity Testing
- 17.3.3 Disease Research
- 17.3.4 Wildlife Conservation
- 17.3.5 Biodefense
- 17.4 Central Asia Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 17.5 Central Asia Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 17.6 Central Asia Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 18 : Oceania Forensic Genomics Market Breakdown by Country, Type & Application
- 18.1 Oceania Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 18.2.1 Next-Generation Sequencing
- 18.2.2 Microarray Analysis
- 18.2.3 PCR-based Methods
- 18.2.4 DNA Barcoding
- 18.2.5 SNP Genotyping
-
18.3 Oceania Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 18.3.1 Crime Investigation
- 18.3.2 Paternity Testing
- 18.3.3 Disease Research
- 18.3.4 Wildlife Conservation
- 18.3.5 Biodefense
- 18.4 Oceania Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 18.5 Oceania Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 18.6 Oceania Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 19 : MEA Forensic Genomics Market Breakdown by Country, Type & Application
- 19.1 MEA Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2025]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2025]
- 19.2.1 Next-Generation Sequencing
- 19.2.2 Microarray Analysis
- 19.2.3 PCR-based Methods
- 19.2.4 DNA Barcoding
- 19.2.5 SNP Genotyping
-
19.3 MEA Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2025]
- 19.3.1 Crime Investigation
- 19.3.2 Paternity Testing
- 19.3.3 Disease Research
- 19.3.4 Wildlife Conservation
- 19.3.5 Biodefense
- 19.4 MEA Forensic Genomics Market by Country (USD Million) & Sales Volume (Units) [2026-2033]
- 19.5 MEA Forensic Genomics Market by Type (USD Million) & Sales Volume (Units) [2026-2033]
- 19.6 MEA Forensic Genomics Market by Application (USD Million) & Sales Volume (Units) [2026-2033]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Global Forensic Genomics market is estimated to see a CAGR of 11.00% and may reach an estimated market size of 11.00% 1.8 Billion by 2033.
The Forensic Genomics Market is predicted to grow at a CAGR of 11.00%.
The changing dynamics and trends such as Next-Gen Sequencing,AI & Machine Learning,Portable Genomics,Data Sharing,Privacy Focus are seen as major Game Changer in Global Forensic Genomics Market.
The leaders in the Global Forensic Genomics Market such as Thermo Fisher Scientific (USA),Illumina (USA),Qiagen (Germany),BGI Genomics (China),Verogen (USA),PerkinElmer (USA),Bio-Rad Laboratories (USA),Eurofins Scientific (Luxembourg),Myriad Genetics (USA),Agilent Technologies (USA),Oxford Nanopore Technologies (UK),Guardant Health (USA),NGS Health (Singapore),Invitae Corporation (USA),Roche Diagnostics (Switzerland) are targeting innovative and differentiated growth drivers some of them are Law Enforcement Demand,Genomic Advances,Data Analytics,Portable Devices,Legal Frameworks
Business transformation in Forensic Genomics Market has taken hold due to the confluence of several important triggers, some of them are Data Security,Ethical Concerns,Cost,Regulatory Complexity,Standardization.
Some of the opportunities that Analyst at HTF MI have identified in Forensic Genomics Market are:
- Growth In Crime Labs
- Personalized Medicine
- Wildlife Forensics
- Biodefense
- Global Collaboration
New entrants, including competitors from unrelated industries along with players such as Thermo Fisher Scientific (USA),Illumina (USA),Qiagen (Germany),BGI Genomics (China),Verogen (USA),PerkinElmer (USA),Bio-Rad Laboratories (USA),Eurofins Scientific (Luxembourg),Myriad Genetics (USA),Agilent Technologies (USA),Oxford Nanopore Technologies (UK),Guardant Health (USA),NGS Health (Singapore),Invitae Corporation (USA),Roche Diagnostics (Switzerland) Instituting a robust process in Global Forensic Genomics Market.
The Global Forensic Genomics Market Study is Broken down by applications such as Crime Investigation,Paternity Testing,Disease Research,Wildlife Conservation,Biodefense.
The Global Forensic Genomics Market Study is segmented by Next-Generation Sequencing,Microarray Analysis,PCR-based Methods,DNA Barcoding,SNP Genotyping.
The Global Forensic Genomics Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2020 - 2025; Base year: 2025; Forecast period: 2025 to 2033
Forensic Genomics employs advanced genomic sequencing and analysis techniques to identify individuals, species, and genetic relationships in forensic investigations and research. It includes next-generation sequencing, microarrays, PCR, and SNP genotyping. Used extensively in law enforcement, paternity testing, disease outbreaks, and wildlife monitoring, this field enables high accuracy, speed, and detailed genetic insights. Innovations focus on rapid sequencing, data analytics, and portable devices to support forensic casework and research globally.
